Carlos E Santos sold $50k of LEGN
Chief Financial Officer at Legend Biotech Corp. 5,430 shares at an average of $9.14, traded Sep 21, 2026, filed Sep 23, 2026.
Score components
- +22RoleCFO
- +7Trade size$50k at market
- +10Share of holdings soldSold 28% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002097065-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | AGrant or award Ordinary Shares | +19,676 | $0.00 | $0 | 19,676 | 19 d ago |
| Sep 21, 2026 | SOpen-market sale Ordinary Shares | -5,430 | $9.14 | $50k | 14,246 | 19 d ago |
Related signals
Other insiders at Legend Biotech Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Legend Biotech Corp | Corazon (Corsee) D. Sanders director | $259k 27,370 shares | -34% | |
| 34Weak | LEGNsell Legend Biotech Corp | Ying Huang Chief Executive Officer | $87k 9,936 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.